Therapeutic potential of curcumin for multiple sclerosis

Area of Science:

• Neuroimmunology
• Pharmacology
• Autoimmune Diseases

Background:

• Multiple sclerosis (MS) is a chronic CNS autoimmune disease involving demyelination and neuroinflammation.
• T helper 17 (Th17) cells and B cells play key roles in MS pathogenesis.
• Oxidative stress is a significant contributing factor to MS development.

Purpose of the Study:

• To summarize the therapeutic potential of curcumin against MS.
• To highlight curcumin's anti-inflammatory and antioxidant properties relevant to MS.
• To explore curcumin's future as a neuroprotective agent for MS.

Main Methods:

• Review of existing literature on curcumin and MS.
• Analysis of curcumin's effects on key inflammatory pathways in MS.
• Evaluation of curcumin's antioxidant and neuroprotective mechanisms.

Main Results:

• Curcumin modulates multiple cell signaling pathways implicated in MS.
• It exhibits potent anti-inflammatory and antioxidant effects relevant to CNS disorders.
• Curcumin can influence cytokines, transcription factors, and cell cycle proteins.

Conclusions:

• Curcumin demonstrates significant therapeutic potential for managing MS.
• Its properties suggest a role in neuroprotection and as a neuropharmacological drug for MS.
• Further research into curcumin's efficacy in MS is warranted.